INTERVIEW

INTERVIEW

INTERVIEW WITH MARIA FLYNN, ADARE PHARMACEUTICALS

Adare Pharma's Maria Flynn talks with ONdrugDelivery about trends in the oral drug development and delivery space, completing the Orbis Biosciences acquisition during a global pandemic, and how the excellent technology portfolio and strategic fit between Orbis and Adare form part of the combined organisation’s unique story.

INTERVIEW

INTERVIEW WITH MILENA BATALLA, PHD, PANARUM

Dr Batalla introduces the company and describes its Proteoral^® technology for the oral delivery of proteins to the bloodstream, therapeutic applications, and products to date. Panarum is an Argentine company and this interview is presented here in Spanish and English, an exciting first for ONdrugDelivery!

INTERVIEW

Sai Shankar

Aptar Pharma

INTERVIEW WITH SAI SHANKAR, ADAM SHAIN & MARCUS BATES

Sai Shankar, Adam Shain and Marcus Bates discuss the full potential of connectivity, coronavirus as a potential accelerator of adoption, and the place of connected drug delivery systems within Aptar Pharma’s broader offering to industry.

INTERVIEW

Steven Kaufman

Stevanato Group

INTERVIEW WITH STEVEN KAUFMAN, STEVANATO & URI BARUCH, CDP

Steven Kaufman and Uri Baruch discuss the recently announced collaboration between their two companies to accelerate the development of a new variable-dose, cartridge-based pen injector platform for diabetes.

INTERVIEW

Dr Gautam N Shetty

Congruence Medical Solutions

INTERVIEW WITH DR SRI MUDUMBA, SANTEN & DR GAUTAM SHETTY, CONGRUENCE

In this interview, Dr Sri Mudumba, Santen, and Dr Gautam N Shetty, Congruence Medical Solutions, share insights from their experience of working together in developing the MDS for ophthalmic injections.

INTERVIEW

Cecile Halte

BD (Becton Dickinson & Company)

Cecile Halte, BD

In this interview, Cécile Halté, Senior Program Manager, Acute Care Segment, for BD Medical – Pharmaceutical Systems. discusses validation studies of the BD Sterifill Advance™ plastic prefilled syringe, which is intended for use in the hospital setting by healthcare professionals either for manual bolus injections, or with infusion pumps.

INTERVIEW

Bob Tilling

Bob Tilling, Kallik

In this interview, Bob Tilling, Business Development Manager at Kallik, shares his insights on best practice for factory labelling.

CONNECTIVITY

Eric Dessertenne

Biocorp

COMPLETING ITS TRANSITION FROM GENESIS TO MATURITY, BIOCORP OPENS NEW HORIZONS

As Biocorp prepares for the market launch of its connected injector pen add-on, Mallya, Eric Dessertenne and Arnaud Guillet share insights about key steps in the company’s development. The article discusses the many partnership Biocorp has entered in to, and includes a mini-interview with Sergio Monti, Plant Manager for one such partner, V.A.R.I.

INTERVIEW

Dr Mircea Despa

BD (Becton Dickinson & Company)

MIRCEA DESPA & DOUG McCLURE, BD

In this interview, Dr Despa and Mr McClure discuss BD’s approach to connecting devices in its portfolio to meet patient, pharma and other stakeholder requirements. Their discussion focuses in particular on safety and security, highlighting the connected wearable injector, BD Libertas™ with Smart Option, as an example.

INTERVIEW

Guillaume Brouet

Aptar Pharma

GUILLAUME BROUET, APTAR PHARMA

Guillaume Brouet talks with ONdrugDelivery Magazine about how Aptar Pharma uses its device development expertise and infrastructure to provide its pharmaceutical company customers a comprehensive services offering around device development, global regulatory approval and commercialisation.

INTERVIEW

Paul Allsop

Bespak

PAUL ALLSOP, MILES KOTTMAN, HANNAH PRIESTLY & JON REED, CONSORT GROUP

Consort Medical's Paul Allsop, Miles Kottman, Hannah Priestly and Jon Reed talk with ONdrugDelivery Magazine about the company’s integrated formulation and device offering, and focus on its simple, low-cost, single unit-dose, spring powered nasal device, Unidose Xtra.

INTERVIEW

Sagar Bejalwar

BD (Becton Dickinson & Company)

SAGAR BEJALWAR, BD MEDICAL – PHARMACEUTICAL SYSTEMS

Sagar Bejalwar discusses the product and clinician needs in delivering hyaluronic acid for cosmetic applications.

INTERVIEW

Dr Alice Maden

BD (Becton Dickinson & Company)

ALICE MADEN & LIONEL MARITAN, BD MEDICAL – PHARMACEUTICAL SYSTEMS

Alice Maden and Lionel Maritan discuss with detailed expert knowledge the benefits of using integrated systems for sophisticated drug device combination products with multiple device subsystems.

INTERVIEW

Dr Norbert Haberland

Datwlyer

NORBERT HABERLAND, DATWYLER

Norbert Haberland discusses Datwyler’s interests in the field of wearable technology in the healthcare sector.

INTERVIEW

Dr John Patton

Dance Biopharm

BILL WELCH, PHILLIPS-MEDISIZE & JOHN PATTON, DANCE BIOPHARM

In this exclusive interview with ONdrugDelivery Magazine, Bill Welch and John Patton discuss inhaled insulin, connectivity and their two companies’ close partnership

INTERVIEW

Tom Van Ginneken

SCHOTT

TOM VAN GINNEKEN, SCHOTT

Tom Van Ginneken discusses the advantages of polymers as a material for primary pharmaceutical packaging and how the company supports pharma manufacturers with engineering capabilities for individualised containers and rapid prototyping.

INTERVIEW

Torsten Maschke

TORSTEN MASCHKE, DATWYLER SEATLING SOLUTIONS

Torsten Maschke discusses the industrialisation of drug delivery, from the perspective of an industrialisation specialist partner for the pharmaceutical industry, looking at the trends in the field today and the advantages of the modern paradigm of partnering.

INTERVIEW

Eric Dessertenne

Biocorp

ERIC DESSERTENNE, BIOCORP

Eric Dessertenne talks in-depth with ONdrugDelivery Magazine about the ways connectivity is developing within the pharmaceutical industry, its likely future course and how Biocorp is positioned.

INTERVIEW

Dr Sundeep Kankanala

BD (Becton Dickinson & Company)

SUNDEEP KANKANALA, BD

Sundeep Kankanala discusses the challenges faced by today’s biopharmaceutical industry, in particular those posed by the need for large volumes and the issues caused by the use of silicone in prefilled syringes.

INTERVIEW

John Merhige

Credence MedSystems

JOHN A MERHIGE, CREDENCE MEDSYSTEMS

John Merhige discusses Credence’s Companion Safety Syringe System, new advances in the product development pipeline, customer/market driven feedback from user studies and exciting developments planned for 2018 that will take the company on to the next major phase in its growth.

INTERVIEW

Fanny Sellier

Nemera

FANNY SELLIER, NEMERA

Talking here with ONDrugDelivery Magazine, Ms Sellier discusses Nemera’s multidose eyedropper system Novelia® for preservative-free formulations. She explains how this platform has been developed to improve patients’ lives.

INTERVIEW

Neil Williams

NEIL WILLIAMS, MEDICOM INNOVATION PARTNER

In this interview with ONdrugDelivery Magazine, Williams discusses the crucial role connectivity is taking in the drug delivery device industry.

INTERVIEW

Torsten Maschke

TORSTEN MASCHKE, DATWYLER SEALING SOLUTIONS

Torsten Maschke has been Chief Executive of the Sealing Solutions division of Datwyler and a member of the group’s Executive Board since October 2016. Before joining Datwyler Group, he was responsible for the worldwide distribution of sealing and damping solutions for the automotive industry at Freudenberg Group (Weinheim, Germany).

INTERVIEW

Steven Kaufman

Bespak

STEVEN R KAUFMAN, BESPAK

Steven Kaufman is Global Business Development Lead at Bespak Europe Ltd, responsible for business development activities related to injectable devices such as auto-injectors and wearable injection systems.

INTERVIEW

Derek Brandt

Sensile Medical

GETTING TO KNOW SENSILE MEDICAL

Chief Executive Officer Derek Brandt and three of his colleagues – Christoph Lüdi, Head of Systems Engineering, Alex Perrier, Senior Technology Manager, and Marco Drüssel, Mechanical Engineering Manager – have all been a part of Sensile Medical for the past ten years, and here reflect on the company’s past and discuss the future.

INTERVIEW

Arnaud Guillet

Biocorp

ARNAUD GUILLET, BIOCORP

Arnaud Guillet discusses Biocorp’s existing connected devices, value for pharmaceutical partners, accompanying software and data architecture and Biocorp's triple expertise in medical devices, electronics and software.

INTERVIEW

Tony Bratt

Nordic Group

TONY BRATT, NORDIC PHARMA

Tony Bratt discusses Nordic Pharma’s specialised market focused business model and how he believes drug delivery systems, in particular the platform device concept, can play an important role in this niche product field.

INTERVIEW

Dimitri Grasswill

Nemera

DIMITRI GRASSWILL, NEMERA

Dimitri Grasswill speaks with ONdrugDelivery Magazine, in the context of the changing market and technology around inhalation devices.

INTERVIEW

Bill Welch

Phillips-Medisize

BILL WELCH, PHILIPS-MEDISIZE

Mr Welch gives ONdrugDelivery Magazine an exclusive preview of Phillips-Medisize’s forthcoming workshop, “Realizing the Benefits of Connected Health in Respiratory Drug Delivery”.

INTERVIEW

Mathias Romacker

MATHIAS ROMACKER, PFIZER

Mathias Romacker shares his thoughts on the emergence of connectivity in drug delivery devices, he explains why he thinks the buzz around connectivity in delivery systems is more than just hype and describes the trends in the pharma sector that mean it makes sense now to connect up devices.

INTERVIEW

Simon Michel

Ypsomed

SIMON MICHEL, CHIEF EXECUTIVE OFFICER, YPSOMED

Simon Michel talks about his vision for how the connected world of drug delivery devices will evolve, and Ypsomed’s central role within it.

INTERVIEW

John Merhige

Credence MedSystems

JOHN A. MERHIGE, CREDENCE MEDSYSTEMS

John Merhige speaks about Credence’s history, people and devices, and what the company’s core philosophy, “Innovation Without Change” is really about, and how much it genuinely means to Credence.

INTERVIEW

Mike Hooven

Enable Injections

GETTING TO KNOW ENABLE INJECTIONS

Here follow five mini-interviews with key Enable members. We asked each of them the same five questions, and their answers give interesting insights, from varied perspectives, into what really makes Enable Injections tic.

INTERVIEW

Dr Elizabeth Shen

Colorcon

DR ELIZABETH SHEN, COLORCON

Elizabeth Shen talks taste-masking, from the positive impact on medication adherence, to technical approaches and technology selection, and regulatory considerations.

INTERVIEW

Mir Imran

Rani Therapeutics

MIR IMRAN, RANI THERAPEUTICS

Mir Imran speaks with ONdrugDelivery Magazine in detail about the innovative “Robotic Pill” technology, currently under development by Rani Therapeutics.

INTERVIEW

Jochen Ratjen

SHL Group

JOCHEN RATJEN, SHL GROUP

Jochen Ratjen shares his insights when approaching the design and development of user-centric autoinjectors.

INTERVIEW

Dr Jeannie Joughin

INTERVIEW: JEANNIE JOUGHIN, CSL BEHRING

Jeannie Joughin speaks exclusively with ONdrugDelivery Magazine about CSL Behring’s agreement with Enable, how it came about, what it means to the two companies, and how it’s going so far.

INTERVIEW

Patrick Alexandre

Crossject

PATRICK ALEXANDRE, CROSSJECT

Shortly after Crossject’s successful IPO on the French NYSE Euronext Paris Exchange (Paris Bourse), Patrick Alexandre spoke about Crossject, its technology and strategy for the future as a publically traded company.